N. Rifai

Epidemiology · 2000–2016

A researcher in the Science corpus: 35 papers; trusts 10 researchers and is trusted by 23 researchers here, as inferred from the citation graph.

Subfields

Epidemiology — 127 citations into it; #114 of 2,148 by trust here, #16 by citations
Endocrinology, Diabetes and Metabolism — 75 citations into it; #71 of 623 by trust here, #27 by citations
Surgery — 75 citations into it; #216 of 1,106 by trust here, #50 by citations
Cardiology and Cardiovascular Medicine — 71 citations into it; #85 of 906 by trust here, #25 by citations
Molecular Biology — 32 citations into it
Oncology — 29 citations into it; #253 of 1,698 by trust here, #119 by citations
Public Health, Environmental and Occupational Health — 26 citations into it; #2,317 of 2,368 by trust here, #132 by citations
Nutrition and Dietetics — 16 citations into it; #655 of 1,029 by trust here, #232 by citations

Whom N. Rifai trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts N. Rifai overall

Papers from N. Rifai's perspective

Ordered by how strongly the researchers N. Rifai trusts endorse each paper. Same corpus, a different order for every researcher.

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. (Journal of the American Medical Association (JAMA))
Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS (Proceedings of the National Academy of Sciences of the United States of America)
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. (Circulation)
The hormone resistin links obesity to diabetes (Nature)
Association between C-reactive protein and features of the metabolic syndrome: a population-based study. (Diabetes Care)
The Need for Guidelines in Publication of Peptide and Protein Identification Data (Molecular & Cellular Proteomics)
Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease (Circulation)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. (The Lancet)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (Journal of the American Medical Association (JAMA))
Cardiovascular morbidity and mortality associated with the metabolic syndrome. (Diabetes Care)

Their papers

Protein biomarker discovery and validation: the long and uncertain path to clinical utility (2006) — 1,820 citations
Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and Men (2009) — 664 citations
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. (2003) — 5,867 citations
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. (2004) — 669 citations
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Med (2016) — 805 citations
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men (2008) — 877 citations
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. (2007) — 1,874 citations
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. (2007) — 1,669 citations
Multiple biomarkers for the prediction of first major cardiovascular events and death. (2006) — 1,399 citations
C-reactive protein levels and outcomes after statin therapy. (2005) — 2,304 citations
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. (2005) — 821 citations
Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. (2005) — 623 citations
Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. (2005) — 963 citations
Prevalence of the Metabolic Syndrome in American Adolescents: Findings From the Third National Health and Nutrition Examination Survey (2004) — 1,124 citations
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. (2004) — 1,413 citations
Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. (2004) — 645 citations
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. (2004) — 1,220 citations
Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. (2004) — 896 citations
Inflammatory markers and the risk of coronary heart disease in men and women. (2004) — 1,250 citations
Inflammatory markers and risk of developing type 2 diabetes in women. (2004) — 832 citations